20 June 2013
Keywords: ppl, begins, trials, cystic, fibrosis, drug, therapeutics
Article | 23 December 1996
- PPL Therapeutics has begun human clinical trials with its cystic
fibrosis therapy, alpha1-antitrypsin (AAT). The placebo-controlled,
Phase I trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
19 June 2013
© 2013 thepharmaletter.com